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Dr Sheng-Shou Hu (Beijing, China). Congratulations, Dr Ra-
stan, for your excellent presentation.
SYNTAX is a widely known study comparing outcomes of
CABGwith PCI in patients with 3-VD or LM disease. The purpose
of the current study is to describe the current status of CABG basedThe Journal of Thoracic and Caon the SYNTAX CABG cohort and to identify risk factors for ad-
verse outcomes with a special focus on the impact of coronary
complexity quantified by SYNTAX score. As far as we know,
the SYNTAX CABG cohort is the largest one analyzed in a single
controlled multicenter clinical trial right now.
One important conclusion from the current study is the excel-
lent contemporary CABG results. Outcome data demonstrate
very low early and follow-up mortality rates. However, CVAs
were relatively common for CABG patients, which may be said
to be a big limitation of modern CABG when compared with
PCI to treat 3-VD or LM chronic disease. Therefore, we cardiac
surgeons need to spare more effort to reduce CVAs in the future.
The SYNTAX score was initially designed as a comprehensive
angiographic scoring system to anticipate PCI complexity related
to coronary disease, and it can serve as risk stratification and risk
prediction for PCI patients. However, the predictive value of the
SYNTAX score for CABG patients is unclear. A recent study
from another group in your home country, a paper published in
the Annals of Thoracic Surgery last year, found that SYNTAX
score was indicative of 1-year outcomes in CABG patients. How-
ever, your study found that 2-year post-CABG outcomes were not
affected by the SYNTAX score. Therefore, future validation of the
SYNTAX score in other patient populations is required.
I have 3 questions. As I just mentioned, a previous study by Dr
Ozcan Birim found that SYNTAX score was indicative for 1-year
outcomes in CABG patients. How do you explain the difference
between your findings and his?
Dr Rastan.Wementioned this paper from the Rotterdam group
in the paper discussion. This study was a single-center analysis on
patients with LM disease, and data suggested that the SYNTAX
score has an impact on the surgical result in about 150 patients.
As you could read, this was hardly discussed afterward even by
the coauthors. I am, however, sure that the SYNTAX trial data,
having 10-fold more patients available, are more convincing and
clearly demonstrated that the SYNTAX score itself does not affect
the results of CABG.
Dr Hu. Second, we found significantly less completeness of
coronary revascularization and worse outcomes of randomized pa-
tients compared with registry patients. This finding was quite un-
expected and surprising, because registry patients were more
likely to have had LM disease and a higher SYNTAX score,
whereas randomized patients were more likely to have had a bilat-
eral ITA used and more arterial grafts. Why were randomized pa-
tients with lower SYNTAX score associated with less complete
coronary revascularization and adverse outcomes? What is your
comment on that?
Dr Rastan. Thank you very much for mentioning this very im-
portant issue. This is one of the key questions from all our analy-
ses. We knew from the SYNTAX 1-year data, and this was
surprising from the very beginning, that there was a remarkable
difference in the 1-year outcome of randomized CABG patients
compared with the CABG registry. We all speculated about the
reason for this finding, because randomized patients were obvi-
ously healthier and had a less complex coronary anatomy. If any-
thing, the results were expected to be better for randomized
patients, not worse. Identifying the reasons for this unexpected
finding in surgical patients was one of the major reasons that we
made this analysis.rdiovascular Surgery c Volume 141, Number 1 139
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DOf note, we found that the difference between randomized and
registry patients was more remarkable in low SYNTAX scores
than in higher SYNTAX scores. The reasons were not the random-
ization itself but the incompleteness of revascularization and the
higher rate of repeat revascularization. The following question
is, why did randomized patients, or patients with a low SYNTAX
score, receive incomplete revascularization more often? This is re-
ally interesting but difficult to explain. Thus, we have to analyze
this issue further. Maybe it is a matter of the lesion-driven
definition of completeness of revascularization that was used in
this study.
Just looking at the territories of the LAD, circumflex, and right
coronary arteries, we found that there were no significant differ-
ences. Thus, it might be possible that the second vessel of a partic-
ular territory could make the difference regarding a potential target
vessel for the interventionalist to make a PCI postoperatively. The
next step is to go more into detail regarding this issue and, more
important, to correlate these finding to the clinical symptoms of
the patient.
Dr John D. Puskas (Atlanta, Ga). I was particularly fascinated
to see that the SYNTAX score did not affect MACCE at 2 years in
surgical patients but did in PCI patients. As you know, there are
have been several criticisms of database analyses comparing vari-
ous techniques for CABG surgery on the basis that the Society of140 The Journal of Thoracic and Cardiovascular SurgThoracic Surgeons database, for example, does not have detailed
data on coronary anatomy. For instance, there have been those
who criticize comparisons of off-pump versus on-pump surgery
within the Society of Thoracic Surgeons database because coro-
nary complexity cannot be adjusted for; you have now shown
that coronary complexity may in fact not affect MACCE at 2 years
when surgery is performed well. I think that is an important point.
The inability to adjust for coronary anatomic complexity does not
invalidate database comparisons of alternative surgical techniques
for CABG.
Dr Rastan. Thank you for this comment. I completely agree
that it is actually difficult to quantify the complexity of coronary
artery disease. The SYNTAX score is a new tool that we have
available. At the moment, it is speculativewhether or not the SYN-
TAX score is really the only true or best instrument to quantify
complexity of coronary artery disease. However, it is complex to
build and there is a significant interobserver and intraobserver
variability. Maybe we should look more at the predictive value
of individual components of the SYNTAX score, such as chronic
total occlusions or the number of diseased lesions, which also
did not affect the surgical results, but might also be predictive
for PCI results. However, we as surgeons should also try to better
quantify the complexity of artery disease. I agree.
Dr Puskas.Congratulations on a very thought-provoking study.ery c January 2011
